Analyst Opinions

Morepen Laboratories enters US prescription generics market

Morepen Laboratories Limited gained 5% to ₹99.15 after launching its first prescription generic drug in the US, ending an eight-session losing streak. The company has introduced Desloratadine Tablets USP, 5 mg, in 100-count and 500-count p… See Moremore

IRB Infra share price climbs 7% - Q2 Earnings

IRB Infra share price climbs 7% as toll collections boost Q2 earnings IRB Infra share price: Strong quarterly results and positive brokerage commentary lifted shares of IRB Infrastructure Developers by nearly 7 per cent in intraday trade o… See Moremore

Data Patterns is showing an interesting example of trendline

DATAPATTNS Data Patterns is showing an interesting example of trendline support and price retracement from a long-term rising support zone. After witnessing a strong rally, the stock entered a corrective phase and gradually moved down to… See Moremore

BDL: INDIA’S MISSILE MANUFACTURING POWERHOUSE 🚀

BDL India’s defence story is moving beyond importing weapons. The focus is increasingly on designing, manufacturing and supplying advanced missile systems domestically. Bharat Dynamics Limited (BDL) is at the heart of this opportunity.… See Moremore

Chalet Hotels: ADR Up 11%, Occupancy Dipped

CHALET Chalet Hotels ( NSE : CHALET) owns and operates upscale hotels and resorts in Mumbai, New Delhi and other cities, alongside select residential projects. It had 11 operating hotels and resorts as of the September 2026 quarter. Ind… See Moremore

Godrej Properties plans to launch homes worth Rs 32,000 cr

GODREJPROP Godrej Properties, the real estate arm of the Godrej Group, is gearing up for a major expansion in the second half of FY27. The Mumbai-based developer plans to bring new housing projects worth Rs 32,000 crore to market between… See Moremore

Olectra Q2 PAT rises 7% YoY to ₹52.94 Cr

OLECTRA Olectra Greentech Limited (OLECTRA) reported consolidated Q2FY27 net profit of ₹52.94 Cr, up 6.84% YoY and 104% QoQ. Revenue from operations rose 4.63% YoY and 19.38% QoQ to ₹687.01 Cr. EBITDA stood at ₹91.77 Cr, up 2.91% YoY and… See Moremore

Ashoka Buildcon secures ₹865.90 crore NHAI order

Ashoka Buildcon Limited (NSE: ASHOKA) has received an LOA from NHAI for an ₹865.90 crore EPC contract, excluding GST. The project covers balance construction work on a 26.6 km section of the 8-lane Vadodara–Mumbai Expressway in Gujarat. Th… See Moremore

HAVELLS – Wednesday Breakout Analysis , Wednesday 11 nov

HAVELLS HAVELLS – Wednesday Breakout Analysis Bullish momentum – Watch for breakout NSE: HAVELLS | Trading date: 11 November 2026 1. Market Trend: Havells closed at ₹1,159.50 on 9 November, gaining 3.25%. RSI was around 66, while MACD was… See Moremore

Loan Disbursements Surge 31%, Net NPAs Improve Significantly

IREDA **IREDA: Loan Disbursements Surge 31%, Net NPAs Improve Significantly** **IREDA** Indian Renewable Energy Development Agency reported steady Q2 FY27 performance, with standalone net profit rising to ₹554 crore compared with ₹549 cro… See Moremore

Whirlpool India Q2 PAT falls 40% to ₹25 Cr

WHIRLPOOL Whirlpool of India Limited (WHIRLPOOL) reported consolidated Q2FY27 net profit of ₹25 Cr, down 40% YoY and 76% QoQ. Revenue from operations rose 14% YoY to ₹1,873 Cr but declined 31% QoQ. Operating profit stood at ₹40 Cr, down… See Moremore

Jyothy Labs raises buyback price to ₹240 per share

Jyothy Labs Limited (NSE: JYOTHYLAB) has increased its buyback price from ₹215 to ₹240 per share, while reducing the maximum shares to 61.25 lakh. The total buyback allocation remains approximately ₹147 crore, representing 1.67% of paid-up… See Moremore

TECH MAHINDRA (NSE: TECHM) – 10 November 2026 ₹1,805

TECHM TECH MAHINDRA (NSE: TECHM) – 10 November 2026 ₹1,805 -1.36% Monday, 9 November closing price ***** +1 Tomorrow's trading levels Level Price Immediate support ₹1,795 Strong support ₹1,789 Breakout entry trigger ₹1,825 Target… See Moremore

Godrej Properties Plans ₹32,000 Cr Launches in H2 FY27

Godrej Properties plans to launch residential projects worth ₹32,000 crore in the second half of FY27, double the ₹16,000 crore launch value recorded during April–September 2026. Key Highlights H1 FY27 project launches: ₹16,000 crore. H2… See Moremore

Gland Pharma Limited's Q2 FY27 profit rises 58%

Gland Pharma Limited (NSE: GLAND) reported Q2 FY27 consolidated revenue of ₹1,834 crore, increasing 23.3% year-on-year. Net profit rose 58.3% to approximately ₹291 crore. The company's CDMO business recorded 31% year-on-year growth. EBITDA… See Moremore

Specialty Chemicals & Electronics Sector – Jubilant Ingrevia

Jubilant Ingrevia Ltd. JUBLINGREA is an Indian specialty chemicals and life-science ingredients company. A major development reported on 9 November 2026 is that its subsidiary, Jubilant Advanced Electronics, entered into an agreement to ac… See Moremore

Datamatics Global Targets ₹3,000 Crore Revenue in 3 Years

Datamatics Global Services Ltd DATAMATICS has outlined an ambitious growth roadmap, targeting ₹3,000 crore in annual revenue over the next three years, supported by an expected compound annual growth rate (CAGR) of approximately 15%. The… See Moremore

Ashoka Buildcon Secures ₹865.90 Crore NHAI Project

ASHOKA ---- Key Details of the ContractProject ----- **Scope: Balance work for the construction of an 8-lane access-controlled expressway (Pkg-IX) from Km 128.0 to Km 154.6 of the Vadodara-Mumbai Expressway, cov… See Moremore

Mankind Pharma Ltd. – Technical Analysis

MANKIND Mankind Pharma is showing strong bullish momentum on the daily chart after recovering from its important support zone around ₹2,190–₹2,250. The stock is currently trading near ₹2,668, supported by a strong bullish candle and encour… See Moremore

L&T Secures Significant Metro Order, Boosting Growth Outlook

LT has secured a significant order from Noida Metro Rail Corporation for the Noida Metro Aqua Line Extension Project, announced on November 9, 2026. What is the development? • Order value: Classified as a significant order, indicating a… See Moremore